| scholarly article | Q13442814 |
| P2093 | author name string | Terry G Unterman | |
| Thomas Kietzmann | |||
| Elitsa Y Dimova | |||
| Goutham Kumar Ganjam | |||
| P2860 | cites work | Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 |
| Direct control of the Forkhead transcription factor AFX by protein kinase B | Q22009452 | ||
| Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions | Q24291233 | ||
| Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase | Q24297207 | ||
| Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity | Q24298021 | ||
| The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanism | Q24302271 | ||
| Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase | Q24310456 | ||
| Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation | Q24534597 | ||
| The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression | Q24670887 | ||
| Unified nomenclature for the winged helix/forkhead transcription factors | Q28145807 | ||
| Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 | Q28216275 | ||
| Mechanism of human SIRT1 activation by resveratrol | Q28238262 | ||
| Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha | Q28274682 | ||
| Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site | Q28286400 | ||
| SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma | Q28301961 | ||
| Stressing the role of FoxO proteins in lifespan and disease | Q28303730 | ||
| The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth | Q28508976 | ||
| Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity | Q28573827 | ||
| Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake | Q28576714 | ||
| SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis | Q28583941 | ||
| Cell cycle and death control: long live Forkheads | Q28646130 | ||
| A third-generation lentivirus vector with a conditional packaging system | Q29616120 | ||
| FOXO transcription factors at the interface between longevity and tumor suppression | Q29620472 | ||
| A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression | Q30828833 | ||
| Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes | Q33878155 | ||
| Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation | Q34089899 | ||
| Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes | Q34214063 | ||
| Rat glucokinase gene: structure and regulation by insulin | Q34284810 | ||
| Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. | Q34335561 | ||
| Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. | Q34457395 | ||
| FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. | Q34521158 | ||
| Resveratrol: a multitargeted agent for age-associated chronic diseases. | Q34590533 | ||
| FOXO transcription factors in the regulatory networks of longevity | Q34637630 | ||
| Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism | Q34945194 | ||
| Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. | Q35049218 | ||
| Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference | Q35182317 | ||
| FoxOs at the crossroads of cellular metabolism, differentiation, and transformation | Q35770614 | ||
| Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1 | Q35921709 | ||
| Calorie restriction, SIRT1 and metabolism: understanding longevity | Q36071224 | ||
| FoxO proteins in insulin action and metabolism | Q36110215 | ||
| Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. | Q36140005 | ||
| Tissue-specific regulation of glucokinase gene expression | Q36270290 | ||
| Dynamic FoxO transcription factors | Q36889897 | ||
| A nucleoprotein complex containing CCAAT/enhancer-binding protein beta interacts with an insulin response sequence in the insulin-like growth factor-binding protein-1 gene and contributes to insulin-regulated gene expression | Q38305808 | ||
| Identification of upstream stimulatory factor as transcriptional activator of the liver promoter of the glucokinase gene | Q38335247 | ||
| FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes | Q39879302 | ||
| Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1. | Q39971127 | ||
| Pancreatic glucokinase is activated by insulin-like growth factor-I. | Q40167658 | ||
| Complete nucleotide sequence of the leader rna synthesized in vitro by vesicular stomatitis virus | Q40177561 | ||
| Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. | Q40477651 | ||
| Liver glucokinase can be activated by peroxisome proliferator-activated receptor-gamma. | Q40594774 | ||
| Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. | Q40609126 | ||
| Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. | Q40636065 | ||
| Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. | Q40667994 | ||
| Orphan receptor HNF-4 and liver-specific gene expression | Q40745186 | ||
| Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences | Q40793631 | ||
| Mammalian glucokinase | Q40844711 | ||
| Mammalian glucokinase and its gene | Q40855958 | ||
| Zonation of parenchymal and nonparenchymal metabolism in liver | Q41138372 | ||
| Arterial oxygen partial pressures reduce the insulin-dependent induction of the perivenously located glucokinase in rat hepatocyte cultures: mimicry of arterial oxygen pressures by H2O2. | Q41826394 | ||
| Resveratrol inhibits insulin responses in a SirT1-independent pathway | Q42150966 | ||
| Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes | Q42176879 | ||
| Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence | Q42472986 | ||
| Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence | Q42477315 | ||
| Activation of glucokinase gene expression by hepatic nuclear factor 4alpha in primary hepatocytes | Q43001938 | ||
| Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBPbeta). Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta | Q43512006 | ||
| The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway | Q44652125 | ||
| Oxygen-dependent regulation of hepatic glucose metabolism | Q44829443 | ||
| SREBP-1c mediates the insulin-dependent hepatic glucokinase expression. | Q44881161 | ||
| Modulation of glucokinase expression by hypoxia-inducible factor 1 and upstream stimulatory factor 2 in primary rat hepatocytes | Q44889088 | ||
| Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes | Q46402217 | ||
| Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting | Q46440389 | ||
| Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. | Q46752037 | ||
| FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression | Q46955933 | ||
| A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding | Q48322350 | ||
| Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver | Q48386175 | ||
| Competitive inhibition of liver glucokinase by its regulatory protein | Q48661122 | ||
| Regulation of SREBP1c gene expression in skeletal muscle: role of retinoid X receptor/liver X receptor and forkhead-O1 transcription factor. | Q51455793 | ||
| Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review | Q57243551 | ||
| Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells | Q61703391 | ||
| Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice | Q73226656 | ||
| Inhibition of CREB- and cAMP response element-mediated gene transcription by the immunosuppressive drugs cyclosporin A and FK506 in T cells | Q73829252 | ||
| Hepatocyte nuclear factor-4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor | Q78767698 | ||
| Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1 | Q79362559 | ||
| P433 | issue | 45 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 30783-30797 | |
| P577 | publication date | 2009-09-09 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | FoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol | |
| P478 | volume | 284 |
| Q35630807 | A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism |
| Q36756228 | AMP-activated protein kinase and its downstream transcriptional pathways |
| Q38344552 | Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice |
| Q39213555 | Acute inhibition of central c-Jun N-terminal kinase restores hypothalamic insulin signalling and alleviates glucose intolerance in diabetic mice |
| Q38676378 | Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4alpha in HepG2 cells |
| Q34981792 | Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis |
| Q34132966 | Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice |
| Q37704641 | FOXO transcription factors protect against the diet-induced fatty liver disease |
| Q36364938 | FOXO1 Up-Regulates Human L-selectin Expression Through Binding to a Consensus FOXO1 Motif |
| Q37893104 | Foods for the prevention of diabetes: how do they work? |
| Q34284954 | FoxOs function synergistically to promote glucose production |
| Q34216085 | GSK3β-dependent phosphorylation alters DNA binding, transactivity and half-life of the transcription factor USF2. |
| Q92967400 | Hallmarks of Aging in the Liver |
| Q38160330 | Hepatic glucose sensing and integrative pathways in the liver |
| Q38323043 | Hypothalamic glycogen synthase kinase 3β has a central role in the regulation of food intake and glucose metabolism. |
| Q33853862 | Impact of dietary polyphenols on carbohydrate metabolism |
| Q42283003 | Inhibiting the expression of hepatocyte nuclear factor 4 alpha attenuates lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice |
| Q38758630 | Insulin-Mediated Downregulation of Apolipoprotein A-I Gene in Human Hepatoma Cell Line HepG2: The Role of Interaction Between FOXO1 and LXRβ Transcription Factors. |
| Q37693826 | Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins |
| Q38031743 | Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons. |
| Q26800264 | Linking diet to acne metabolomics, inflammation, and comedogenesis: an update |
| Q36004187 | Menin liver-specific hemizygous mice challenged with high fat diet show increased weight gain and markers of metabolic impairment |
| Q54616061 | Modulation of NF-κB and FOXOs by baicalein attenuates the radiation-induced inflammatory process in mouse kidney. |
| Q49325511 | Natural products, an important resource for discovery of multitarget drugs and functional food for regulation of hepatic glucose metabolism |
| Q51034856 | Phenolic compounds increase the transcription of mouse intestinal maltase-glucoamylase and sucrase-isomaltase. |
| Q36088244 | Prediction and Validation of Transcription Factors Modulating the Expression of Sestrin3 Gene Using an Integrated Computational and Experimental Approach. |
| Q33619008 | Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice |
| Q57476675 | Resveratrol long-term treatment differentiates INS-1E beta-cell towards improved glucose response and insulin secretion |
| Q33850299 | Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1 |
| Q47825027 | Resveratrol supplementation improves lipid and glucose metabolism in high-fat diet-fed blunt snout bream. |
| Q35052100 | Resveratrol-activated SIRT1 in liver and pancreatic β-cells: a Janus head looking to the same direction of metabolic homeostasis |
| Q36220473 | Role of transcription factor acetylation in the regulation of metabolic homeostasis |
| Q47620022 | Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling |
| Q34240759 | Survival strategies of a sterol auxotroph |
| Q27335106 | The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner |
| Q35814179 | Transcriptional Factors Mediating Retinoic Acid Signals in the Control of Energy Metabolism |
| Q37782072 | Transcriptional regulation of energy metabolism in the liver |
| Q35796349 | Transcriptional regulation of glucose sensors in pancreatic β-cells and liver: an update. |
Search more.